DC excipient

FROM CHALLENGE TO TRIUMPH Formulating a 500 mg chewable Vitamin C tablet proved especially difficult due to the ingredient’s poor...

Abstract Background/Objectives: The integration of artificial intelligence (AI) into pharmaceutical development has the potential to accelerate early-stage formulation design. In this...

In oral solid dosage forms, lactose is often described as a filler. This description is accurate, but it can be...

Abstract Oral diseases cause a wide range of difficulties for patients. The natural bioactive compound dihydroquercetin (DHQ), which demonstrates regenerative,...

FROM CHALLENGE TO TRIUMPH Probiotics are highly sensitive to mechanical stress and moisture, making them difficult to formulate into direct...

Abstract Background/Objectives: Excipients play a key role in the manufacturability and performance of solid oral dosage forms, particularly for drug...

New Armor Pharma study! Armor Pharma has released a groundbreaking study conducted by Marie Charbaut, our Technical Support Manager. It...

Abstract Dissolution testing is performed to understand the rate and extent of drug release for assurance of in vivo bioavailability. In this...

FROM CHALLENGE TO TRIUMPH Formulating a 300 mg tablet of micronized Tenofovir Disoproxil Fumarate (TDF) posed significant challenges due to...

FROM CHALLENGE TO TRIUMPH Formulating high‑dose, poorly compressible APIs like Diosmin is challenging due to their fine particle size, irregular...